AAP will campaign for BJP in Lok Sabha polls if Delhi granted statehood: Kejriwal

Agencies
June 12, 2018

New Delhi, Jun 12: In a rhetorical speech in the Delhi assembly, Chief Minister Arvind Kejriwal announced that the AAP would campaign for the BJP during the 2019 Lok Sabha election if Delhi was granted full statehood.

He also warned that if the Modi government failed to do so, the party would conduct a "BJP, quit Delhi" campaign.

"I want to say to BJP, give full statehood status to Delhi before Lok Sabha polls, every vote of people will go in favour of BJP and we (AAP) will campaign for them in Lok Sabha election," Kejriwal said in the assembly.

"But, if they (BJP) do not give full statehood to Delhi, people here will say that BJP walon, Delhi chodo (BJP, quit Delhi)," he added.

Speaking on the government's resolution that seeks full statehood status for Delhi that was adopted in the assembly, Kejriwal sought to know from Prime Minister Narendra Modi whether his promise to give full statehood to Delhi during the 2014 Lok Sabha election was just a "jumla" (election rhetoric).

"We will have to fight for development of Delhi, our children's future... I want to ask Modi ji that he had promised full statehood status to Delhiites during the last Lok Sabha election. I want to ask him whether it was 'jumla'," he said.

Lok Sabha elections are scheduled to be held in 2019. Ahead of polls, the Arvind Kejriwal-led Aam Aadmi Party has decided to strongly raise the issue of full statehood among people in Delhi.

Under its campaign, AAP has given workers a slogan - "LG, quit Delhi"

In the 2014 Lok Sabha polls, BJP had won all seven seats in Delhi.

Kejriwal alleged that the people of Delhi were being "harassed" by the Centre at a scale the British had not done during their rule.

Equating the lieutenant governor with viceroys during the British rules, Kejriwal said that Delhi was being ruled by "Kings" since 1556, adding that in 1947, India got independence, but Delhi is yet to get "freedom" as they (Centre) have appointed L-G in place of viceroys, who is ruling the national capital.

"There is no people's rule in Delhi. King L-G is running Delhi...I want to ask why we (Delhiites) have not got freedom yet. Our ancestors had also fought for India's freedom..." Kejriwal said in the Delhi Assembly.

Giving a call for "freedom of Delhi", the AAP's national convener said that the time has come for the people of Delhi to "fight for their freedom" and implement the "people's rule" in Delhi, and "throw away L-G's rule".

Invoking Bal Gangahar Tilak, Kejriwal said, "Swaraj mera Janam sidh adikar hai (Swaraj is my birthright)...we will implement swaraj in Delhi as L-G is only accountable to the prime minister, and not the people of Delhi."

He said that in 1992, the central government had made a system to hold elections in Delhi as the British had done the same in 1935 under which elections used to be held, but "viceroys had power".

"The Centre had made a bad joke with Delhi in 1992. I want to ask why Delhiites are treated as second class citizens. Why are we half citizens? Why the cost of Delhiites' vote is zero?" he said.

Kejriwal said that in Delhi, "BJP's L-G" doesn't allow the government to work, adding that "King L-G" creates hurdles in the government's work.

Yesterday, eyeing Lok Sabha elections, the AAP has decided to hold meeting at 300 locations across Delhi on the issue of full statehood to Delhi.

Under the plan, the AAP will also hold workers' convention on July 1 where Kejriwal will address party workers on the issue.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 15,2020

Vishakhapatnam, May 15: LG Chem on Thursday said following the gas leak at its Visakhapatnam polymers plant, the company has started support measures and has begun the transportation of the Styrene Monomer inventory to South Korea to eliminate all risks factors.

The company would continue to work with government agencies to ensure all possible support for bereaved families and victims, LG Polymers, a step-down firm of LG Chem, said in a statement.

"We confirm the status-quo of the plant remains completely controlled by all measures. We have begun the transportation of the Styrene Monomer (SM) inventory within the plant as well as in the styrene tanks at the port by vessels to South Korea to prevent and eliminate all risks factors," the statement said.

The South Korean chemicals giant has sent an eight-member team from Seoul to investigate the Visakhapatnam gas leak incident and rehabilitate the victims of the tragedy that killed at least 11 people and forced the evacuation of thousands.

"The team of production, environment, and safety experts are currently investigating the cause of the incident and already supporting responsible rehabilitation which is their main objective," the statement said.

Furthermore, the team is working closely with related authorities to analyze the cause of the incident, prevent a recurrence, and support damage recovery in a prompt and expedient manner, it added.

On the support measures, the company said a special task force is currently supporting the bereaved victims and families and visiting them at the hospitals and their homes.

Besides, food and medical services have been organized for the returning residents. Various support activities such as supplying medical and household goods and sanitation of homes will be continued, it said.

"We assure everyone we will do our best to resolve the situation and prevent any incident in the future," the company said.

The company further said that "our teams will carry out mid-to-long-term Corporate Social Responsibility (CSR) projects that can contribute to the local community based on suggestions of the residents.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 26,2020

Dubai, Apr 26: The Central Bank of the UAE (CBUAE) has instructed financial institutions in the country to search and freeze all bank accounts of Indian billionaire BR Shetty and his family along with those of companies where he has a stake.

The apex bank has also blacklisted several firms associated with Shetty along with their entire senior management.

In an advisory issued last week, CBUAE cited decisions of the Federal Attorney General and asked financial institutions to search and freeze any bank accounts, deposits or investments in the name of Shetty or his family members.

Financial institutions have been directed to stop transfers from these accounts and deny access to deposit boxes.

Currently in India and facing a string of charges, Shetty is the founder of NMC Health.

The heathcare provider was placed into administration by a UK court recently following an application by the Abu Dhabi Commercial Bank (ADCB) which alone has an exposure of $981 million (Dh3.6 billion).

Overall, UAE banks have a combined exposure of more than Dh8bn to NMC which owes money to Oman-based banks and financial institutions as well.

Probing credit facilities
The Central Bank has sought information about credit facilites extended to the Shettys along with details of their safe deposit boxes and the financial transfers they have made till date.

A similar advisory has been issued for NMC Healthcare and NMC Holding, based on the decision of the Head of Plenary Fund Prosecution.

The Central Bank has also blacklisted several companies associated with Shetty. Key staff members of these firms have been similarly blacklisted.

Comments

Angry Indian
 - 
Monday, 27 Apr 2020

when you make money with good country you should not make doka to that country, first of all we indian have bad name in GCC now this will make more dought on indian hindus..

 

after BJP come to power in india,our country is acting like maron, this will only end with final WAR.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.